SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jonathan E. Barsa, Andrea D. Branch, Thomas D. Schiano, A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post-liver transplantation?, Clinical Transplantation, 2015, 29, 10
  2. 2
    Hermien Hartog, Christine J.H. May, Chris Corbett, Angela Phillips, Jeremy W. Tomlinson, Hynek Mergental, John Isaac, Simon Bramhall, Darius F. Mirza, Paolo Muiesan, M. Thamara P.R. Perera, Early occurrence of new-onset diabetes after transplantation is related to type of liver graft and warm ischaemic injury, Liver International, 2015, 35, 6
  3. 3
    T. R. Lim, D. J. Mutimer, Editorial: the association of hepatitis C virus infection and post-liver transplant diabetes, Alimentary Pharmacology & Therapeutics, 2015, 41, 5
  4. 4
    Hwee Leong Tan, Kieron B. L. Lim, Shridhar Ganpathi Iyer, Stephen K. Y. Chang, Krishnakumar Madhavan, Alfred W. C. Kow, Metabolic syndrome after a liver transplantation in an Asian population, HPB, 2015, 17, 8
  5. 5
    Z. Younossi, M. Stepanova, S. Saab, G. Trimble, A. Mishra, L. Henry, The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients, Alimentary Pharmacology & Therapeutics, 2015, 41, 2
  6. 6
    Francesco Negro, Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases, Journal of Hepatology, 2014, 61, 1, S69

    CrossRef

  7. 7
    Kamran Bagheri Lankarani, Ahad Eshraghian, Saman Nikeghbalian, Parisa Janghorban, Seyed Ali Malek-Hosseini, New Onset Diabetes and Impaired Fasting Glucose After Liver Transplant: Risk Analysis and the Impact of Tacrolimus Dose, Experimental and Clinical Transplantation, 2014, 12, 1, 46

    CrossRef

  8. 8
    G. Gámán, E. Sárváry, F. Gelley, A. Doros, D. Görög, I. Fehérvári, L. Kóbori, L. Wágner, B. Nemes, New-Onset Diabetes Mellitus and the Analysis of Dipeptidyl-Peptidase-4 After Liver Transplantation, Transplantation Proceedings, 2014, 46, 6, 2177

    CrossRef

  9. 9
    T. Abe, T. Onoe, H. Tahara, H. Tashiro, K. Ishiyama, K. Ide, M. Ohira, H. Ohdan, Risk Factors for Development of New-Onset Diabetes Mellitus and Progressive Impairment of Glucose Metabolism After Living-Donor Liver Transplantation, Transplantation Proceedings, 2014, 46, 3, 865

    CrossRef

  10. 10
    Masaki Honda, Katsuhiro Asonuma, Shintaro Hayashida, Hiroko Suda, Yuki Ohya, Kwang-Jong Lee, Hidekazu Yamamoto, Takayuki Takeichi, Yukihiro Inomata, Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients, Clinical Transplantation, 2013, 27, 3
  11. 11
    Alessandra Mangia, Maria Ripoli, Insulin resistance, steatosis and hepatitis C virus, Hepatology International, 2013, 7, S2, 782

    CrossRef

  12. You have free access to this content12
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  13. 13
    Geeta S. Karnik, Kirti Shetty, Management of Recurrent Hepatitis C in Orthotopic Liver Transplant Recipients, Infectious Disease Clinics of North America, 2013, 27, 2, 285

    CrossRef

  14. 14
    Anitha D. Yadav, Yu-Hui Chang, Bashar A. Aqel, Thomas J. Byrne, Harini A. Chakkera, David D. Douglas, David C. Mulligan, Jorge Rakela, Hugo E. Vargas, Elizabeth J. Carey, New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database, Journal of Transplantation, 2013, 2013, 1

    CrossRef

  15. 15
    Nobuhiro Harada, Yasuhiko Sugawara, Nobuhisa Akamatsu, Junichi Kaneko, Sumihito Tamura, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Noriyo Yamashiki, Norihiro Kokudo, New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience, Journal of Hepato-Biliary-Pancreatic Sciences, 2013, 20, 6
  16. 16
    Woo Jin Chung, Chronic Hepatitis C and Insulin Resistance, The Korean Journal of Gastroenterology, 2012, 59, 4, 268

    CrossRef

  17. 17
    E. J. Gane, Diabetes Mellitus Following Liver Transplantation in Patients With Hepatitis C Virus: Risks and Consequences, American Journal of Transplantation, 2012, 12, 3
  18. 18
    Kieron B. L. Lim, Thomas D. Schiano, Long-Term Outcome After Liver Transplantation, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2012, 79, 2
  19. 19
    Anna Linda Zignego, Laura Gragnani, Carlo Giannini, Giacomo Laffi, The hepatitis C virus infection as a systemic disease, Internal and Emergency Medicine, 2012, 7, S3, 201

    CrossRef

  20. 20
    Elisabetta Bugianesi, Federico Salamone, Francesco Negro, The interaction of metabolic factors with HCV infection: Does it matter?, Journal of Hepatology, 2012, 56, S56

    CrossRef

  21. 21
    Andres Duarte-Rojo, Elizabeth Jenny Heathcote, Jordan Jay Feld, ‘Easy to treat’ genotypes were not created equal: Can rapid virological response (RVR) level the playing field?, Journal of Hepatology, 2011, 55, 2, 466

    CrossRef

  22. 22
    Vincent Kaddai, Francesco Negro, Current understanding of insulin resistance in hepatitis C, Expert Review of Gastroenterology & Hepatology, 2011, 5, 4, 503

    CrossRef

  23. 23
    Julie A. Thompson, John R. Lake, Liver Transplantation for Hepatitis C: Disease Management, Current Hepatitis Reports, 2011, 10, 1, 41

    CrossRef

  24. 24
    G.P. Sorice, G. Muscogiuri, T. Mezza, A. Prioletta, A. Giaccari, Metabolic Syndrome in Transplant Patients: An Academic or a Health Burden?, Transplantation Proceedings, 2011, 43, 1, 313

    CrossRef

  25. 25
    Sanjaya K. Satapathy, Michael R. Charlton, Posttransplant metabolic syndrome: New evidence of an epidemic and recommendations for management , Liver Transplantation, 2011, 17, 1
  26. 26
    Stefan G. Hübscher, Steatosis and fibrosis progression in patients with recurrent hepatitis C infection: Complex interactions providing diagnostic and therapeutic challenges, Liver Transplantation, 2011, 17, 12
  27. 27
    Ira M. Jacobson, Patrice Cacoub, Luigino Dal Maso, Stephen A. Harrison, Zobair M. Younossi, Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver, Clinical Gastroenterology and Hepatology, 2010, 8, 12, 1017

    CrossRef

  28. 28
    Kymberly D.S. Watt, Michael R. Charlton, Metabolic syndrome and liver transplantation: A review and guide to management, Journal of Hepatology, 2010, 53, 1, 199

    CrossRef

  29. 29
    Hung-Tien Kuo, Marcelo Santos Sampaio, Xiaoyi Ye, Pavani Reddy, Paul Martin, Suphamai Bunnapradist, Risk Factors for New-Onset Diabetes Mellitus in Adult Liver Transplant Recipients, an Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing Database, Transplantation, 2010, 89, 9, 1134

    CrossRef

  30. 30
    Francesco Negro, Metabolic Factors and Steatosis in Patients with Hepatitis B and C,